The Haemophilia Society said it expects NICE's new guidance to be confirmed in March with Altuvoct becoming available in July. Availability of the product through the NHS in Wales, Scotland and ...

Qfitlia reduced annualized bleeding rates by 71%-73% in hemophilia patients. FDA also approved Siemens Healthineers’ INNOVANCE Antithrombin assay as a companion diagnostic to measure AT levels ...

I’m deeply invested in raising Samairra with values that will help her contribute to society. There’s never been a reason to stress, as she’s always been a wonderful, compassionate ...

It has the potential to significantly improve the quality of life of those who are eligible for such treatment,” said Clive Smith, chair of the Haemophilia Society. “Gene therapy provides an ...

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent ...

Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU that can be delivered via an autoinjector device at home.

The U.S. Food and Drug Administration approved Qfitlia for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older ...

Rivals, the Disney+ series about sex and scandal in the British television industry in the 1980s, was one of the big winners at the Royal Television Society (RTS) Progamme Awards. At a ceremony in ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...